Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Expert panel calls for raising the bar in treating schizophrenia

21.12.2004


National survey shows patients want treatments to control broader range of symptoms giving them a second chance at life



A panel of experts says doctors treating patients with schizophrenia should be targeting symptoms beyond hallucinations and delusions, and focus in on the common, but often overlooked, symptoms of depression and anxiety, as well as the inability to think clearly. Patients agree, ranking these symptoms as major concerns in a recent national survey. As a result, the expert panel, convened by MBL Communications, Inc., publishers of the trade journals Primary Psychiatry and CNS Spectrums, will be issuing a consensus statement about new treatment goals for schizophrenia.

"For decades, psychiatry has focused almost solely on managing a patient’s ’positive symptoms,’ such as hallucinations and delusions, because for previous treatments, that is pretty much all we had to offer," said Philip D. Harvey, PhD, professor of psychiatry at Mount Sinai School of Medicine and chief psychologist at Mount Sinai Hospital. "Today, patients and physicians should expect that more of the disease symptoms can be controlled, and that people with schizophrenia can have a more meaningful life."


With the advent of atypical antipsychotics, it is now possible to effectively treat the positive symptoms of hallucinations and delusions, as well as affective symptoms such as depression and anxiety. Furthermore, cognitive impairment (such as the inability to think clearly and difficulty concentrating) and impaired social function can also be alleviated. By targeting the broader spectrum of symptoms, these medications allow patients to function better in daily life.

"It takes time for advances in care to actually be used by physicians to benefit patients," said David Ginsberg, MD, section editor, MBL Communications, Inc. and director, Outpatient Services, Tisch Hospital Department of Psychiatry at New York University Medical Center. "The recent major advances we have seen in the treatment of schizophrenia are so important that we feel physicians need to expand upon their expectations to encompass a broader view of the patient. The development of a consensus statement is one step in that direction."

According to the survey, revealed for the first time during the panel discussion, patients report that it is "very important" for them to have the symptoms of hallucinations and delusions controlled, as well as depression and the inability to think clearly, concentrate or remember. Almost all of those surveyed (94%) believe that improved daily functioning is part of successful treatment for their illness, including the ability to work, shop and participate in hobbies as they normally would.

"Research shows that affective and cognitive symptoms have a tremendous impact on the suffering and frustrations that patients struggle with in order to cope with this difficult illness. It is these symptoms that are the greatest barriers to achieving a meaningful social and professional recovery," said Peter J. Weiden, MD, professor of psychiatry and director of the Schizophrenia Research Service at State University of New York (SUNY) Downstate Medical Center in Brooklyn. "This survey shows that patients are often ahead of their doctors in knowing the importance of affective and cognitive symptoms."

The panelists also included: Peter Buckley, MD, professor and chairman of the Department of Psychiatry and Behavioral Health at the Medical College of Georgia and Nina R. Schooler, PhD, adjunct professor of psychiatry at Georgetown University School of Medicine. Their presentations and aspects of the patient survey results will be published as a supplement in the February issues of CNS Spectrums and Primary Psychiatry.

Elaine Metcalf | EurekAlert!
Further information:
http://www.mblcommunications.com
http://www.ccapr.com

More articles from Health and Medicine:

nachricht New malaria analysis method reveals disease severity in minutes
14.08.2017 | University of British Columbia

nachricht New type of blood cells work as indicators of autoimmunity
14.08.2017 | Instituto de Medicina Molecular

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

A Map of the Cell’s Power Station

18.08.2017 | Life Sciences

Engineering team images tiny quasicrystals as they form

18.08.2017 | Physics and Astronomy

Researchers printed graphene-like materials with inkjet

18.08.2017 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>